Who are Catheter Precision, Inc.'s main suppliers?

Catheter Precision, Inc. (VTAK) key suppliers include: CREATD-INC, SEG-JETS-LLC, VOLATO-GROUP-INC, PEACS-NV, Abbott Laboratories and 4 more. View the full supplier network at chainsifter.com/chain/VTAK.

Who are Catheter Precision, Inc.'s major customers?

Catheter Precision, Inc. (VTAK) key customers include: Abbott Laboratories, Abbott Laboratories, Johnson & Johnson, Johnson & Johnson, BOSTON-SCIENTIFIC-CORP and 6 more. View the full customer network at chainsifter.com/chain/VTAK.

What sector is Catheter Precision, Inc. in?

Catheter Precision, Inc. (VTAK) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Catheter Precision, Inc. Suppliers, Customers & Supply Chain (VTAK)

9Suppliers

11Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Catheter Precision, Inc. (VTAK) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

23Total relationships

7Distinct source URLs

7High confidence

0.742Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Catheter Precision, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CREATD-INC	CREATD-INC	92%	the Company agreed to acquire from Creatd (i) 800,200 shares of the issued and outstanding common stock, par value $0.001 per share, of Fly Flyte, Inc.
SEG-JETS-LLC	SEG-JETS-LLC	92%	the Company agreed to purchase from SEG Jets common stock of Fly Flyte, Inc. in consideration for the Company agreeing to issue and sell in a private placement 5,250 shares of the Company's preferred stock
VOLATO-GROUP-INC	VOLATO-GROUP-INC	92%	As consideration for the Company’s participation in the Private Placement, Volato has agreed to deliver to the Company certain freely tradeable equity securities of a third-party entity, as further d…
PEACS-NV	PEACS-NV	80%	we entered into a certain Software and Technology License Agreement with PEACS, NV, a Netherlands company
ABT	Abbott Laboratories	72%	luoroscopy systems (similar to x-ray in real time). The EP market includes large medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J) and Boston Scientific Co…
ABT	Abbott Laboratories	72%	Reciprocal relationship from ABT graph: Reciprocal relationship from VTAK graph: luoroscopy systems (similar to x-ray in real time). The EP market includes large medical device companies such as Medt…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from VTAK graph: gulatory agencies. Our products may be subject to additional recalls, revocations or suspensions after receiving FDA o…
JNJ	Johnson & Johnson	72%	gulatory agencies. Our products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which could divert managerial and financial reso…
CARDIONOMIX	CARDIONOMIX	70%	Cardionomix acquired the CPNS System

Catheter Precision, Inc. Customers

Ticker	Name	Confidence	Evidence
ABT	Abbott Laboratories	72%	luoroscopy systems (similar to x-ray in real time). The EP market includes large medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J) and Boston Scientific Co…
ABT	Abbott Laboratories	72%	Reciprocal relationship from ABT graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from ABT graph: Reciprocal relationship from VTAK graph: luoroscopy systems (similar to x-ray …
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from VTAK graph: gulatory agencies. Our products may b…
JNJ	Johnson & Johnson	72%	gulatory agencies. Our products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which could divert managerial and financial reso…
BOSTON-SCIENTIFIC-CORP	BOSTON-SCIENTIFIC-CORP	62%	s (similar to x-ray in real time). The EP market includes large medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J) and Boston Scientific Corp. LockeT’s dire…
BSX	Boston Scientific Corporation	62%	Reciprocal relationship from BSX graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from BSX graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from BSX grap…
CARDIOFRONT-LLC	CARDIOFRONT-LLC	62%	e designed to serve underserved regional markets. 54 Table of Contents Recent Developments PeriKard Asset Acquisition On January 14, 2025, we entered into a Membership Interest Purchase Agreement ("A…
FLY-FLYTE-INC	FLY-FLYTE-INC	62%	aviation services. Fly Flyte, Inc. (“FLYTE”) historically has generally provided private aviation services to individuals and individual entities on a per-trip basis, without use of a membership-only…
PERIKARD-LLC	PERIKARD-LLC	62%	e designed to serve underserved regional markets. 54 Table of Contents Recent Developments PeriKard Asset Acquisition On January 14, 2025, we entered into a Membership Interest Purchase Agreement ("A…
SEG-JETS-LLC	SEG-JETS-LLC	62%	lty equal to 11.82 % of net sales of its LockeT device on a quarterly basis, commencing upon the first commercial sale, which occurred in April 2024, through December 31, 2035. In April 2025, a US pa…
STRATOSPHERE-DEVELOPMENT-CO-LLC	STRATOSPHERE-DEVELOPMENT-CO-LLC	62%	lty equal to 11.82 % of net sales of its LockeT device on a quarterly basis, commencing upon the first commercial sale, which occurred in April 2024, through December 31, 2035. In April 2025, a US pa…

Catheter Precision, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
VTAK-DEBT-13456	Warrants outstanding: 20502073	90%	xbrl warrant detail from xbrl 2025-12-31.
VTAK-DEBT	Debt stack $9.6M	90%	Market cache reports total debt of $9.6M.
VTAK-DEBT-13457	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Catheter Precision, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Catheter Precision, Inc..

Catheter Precision, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Catheter Precision, Inc..

Catheter Precision, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
IVA	Inventiva S.A.	100.00	2
SVA	Sinovac Biotech Ltd.	100.00	2
GIKLY	Grifols, S.A.	100.00	2
GIFOF	Grifols, S.A.	100.00	2
IINN	Inspira Technologies Oxy B.H.N. Ltd.	100.00	2
NVS	Novartis AG	100.00	2
GCTK	GlucoTrack, Inc.	100.00	2
FLGT	Fulgent Genetics, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
EXAS	Exact Sciences Corp	100.00	2
GIFLF	Grifols, S.A.	100.00	2
ITGR	Integer Holdings Corporation	100.00	2
NBP	NovaBridge Biosciences	100.00	2
GRAL	GRAIL, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
ALVO	Alvotech	100.00	2
ABT	Abbott Laboratories	100.00	1	['customer', 'supplier']
GRFS	Grifols, S.A.	100.00	2
BSX	Boston Scientific Corporation	100.00	1	['customer']
MTLS	Materialise NV	100.00	2

Catheter Precision, Inc. Supply Chain